CLINICAL_TRIALS
trial_result
· 2020-03-13
Clinical Trial Update: Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 clinical trial update for TQ-F3083 capsules in adults with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: UNKNOWN